These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26235988)

  • 21. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.
    Bai X; Dinghong Q; Miao D; Goltzman D; Karaplis AC
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E79-88. PubMed ID: 18984852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.
    Xiao Z; King G; Mancarella S; Munkhsaikhan U; Cao L; Cai C; Quarles LD
    JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31801907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF23, klotho and vitamin D interactions: What have we learned from in vivo mouse genetics studies?
    Razzaque MS
    Adv Exp Med Biol; 2012; 728():84-91. PubMed ID: 22396163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
    Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
    J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fibroblast Growth Factor 23-Klotho: a new axis of phosphate balance control].
    Prié D; Ureña Torres P; Friedlander G
    Med Sci (Paris); 2009 May; 25(5):489-95. PubMed ID: 19480830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice.
    Andrukhova O; Schüler C; Bergow C; Petric A; Erben RG
    Front Endocrinol (Lausanne); 2018; 9():311. PubMed ID: 29942284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4.
    Gattineni J; Twombley K; Goetz R; Mohammadi M; Baum M
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F371-7. PubMed ID: 21561999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xeno-Klotho Inhibits Parathyroid Hormone Signaling.
    Takenaka T; Inoue T; Miyazaki T; Hayashi M; Suzuki H
    J Bone Miner Res; 2016 Feb; 31(2):455-62. PubMed ID: 26287968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.
    Nakatani T; Sarraj B; Ohnishi M; Densmore MJ; Taguchi T; Goetz R; Mohammadi M; Lanske B; Razzaque MS
    FASEB J; 2009 Feb; 23(2):433-41. PubMed ID: 18835926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men.
    Daryadel A; Bettoni C; Haider T; Imenez Silva PH; Schnitzbauer U; Pastor-Arroyo EM; Wenger RH; Gassmann M; Wagner CA
    Pflugers Arch; 2018 Oct; 470(10):1569-1582. PubMed ID: 29961920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Klotho/FGF23 Axis in CKD.
    Tsuchiya K; Nagano N; Nitta K
    Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
    Carrillo-López N; Panizo S; Alonso-Montes C; Román-García P; Rodríguez I; Martínez-Salgado C; Dusso AS; Naves M; Cannata-Andía JB
    Kidney Int; 2016 Jul; 90(1):77-89. PubMed ID: 27165819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
    Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
    Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
    Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
    J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possible role of the FGF23-Klotho axis in bone mineralization].
    Shimada T
    Clin Calcium; 2007 Oct; 17(10):1548-53. PubMed ID: 17906407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormonal regulation of phosphate balance].
    Tanaka H; Fukagawa M
    Clin Calcium; 2012 Oct; 22(10):1477-85. PubMed ID: 23023626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice.
    Yuan Q; Jiang Y; Zhao X; Sato T; Densmore M; Schüler C; Erben RG; McKee MD; Lanske B
    J Bone Miner Res; 2014 Mar; 29(3):693-704. PubMed ID: 24038141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D Receptor Mediates a Myriad of Biological Actions Dependent on Its 1,25-Dihydroxyvitamin D Ligand: Distinct Regulatory Themes Revealed by Induction of Klotho and Fibroblast Growth Factor-23.
    Haussler MR; Livingston S; Sabir ZL; Haussler CA; Jurutka PW
    JBMR Plus; 2021 Jan; 5(1):e10432. PubMed ID: 33553988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteocytic FGF23 and Its Kidney Function.
    Agoro R; Ni P; Noonan ML; White KE
    Front Endocrinol (Lausanne); 2020; 11():592. PubMed ID: 32982979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.